All Stories

  1. An optimized protocol to isolate quiescent washed platelets from human whole blood and generate platelet releasate under clinical conditions
  2. Toward standardization and a concerted vision for platelet proteomics research: communication from the SSC of the ISTH
  3. Direct Oral Anticoagulants Are Comparable to Low Molecular Weight Heparin at Sustaining the Circulating Extracellular Vesicle and Inflammatory Profiles of Cancer Associated Thrombosis Patients: An Observational Pilot Study
  4. Production of platelets <i>in vitro</i> in functionalised 3-dimensional scaffolds mimicking the bone marrow niche
  5. Unique Patterns of Circulating Extracellular Vesicles in Preterm Infants During Adaptation to Extra‐Uterine Life
  6. Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease
  7. Characterisation of Platelet Releasate Proteome in Relapsing‐Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics
  8. Increasing clinical recruitment rate to a single-site observational study: a quality improvement study
  9. Platelet-derived extracellular vesicles in cardiovascular disease and treatment – from maintaining homeostasis to targeted drug delivery
  10. Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms
  11. Extracellular vesicles in disorders of hemostasis following traumatic brain injury
  12. The effect of UVA light/8-methoxypsoralen exposure used in Extracorporeal Photopheresis treatment on platelets and extracellular vesicles
  13. Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism
  14. Translating genomic tools to Raman spectroscopy analysis enables high-dimensional tissue characterization on molecular resolution
  15. An optimized protocol to isolate quiescent washed platelets from human whole blood and generate platelet releasate under clinical conditions
  16. Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells
  17. ACKR3 regulates platelet activation and ischemia-reperfusion tissue injury
  18. Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis
  19. Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination
  20. Haematological parameters and coagulation in umbilical cord blood following COVID-19 infection in pregnancy
  21. Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade
  22. Nonvalvular atrial fibrillation patients anticoagulated with rivaroxaban compared with warfarin exhibit reduced circulating extracellular vesicles with attenuated pro‐inflammatory protein signatures
  23. The role of the calibrated automated thrombogram in neonates: describing mechanisms of neonatal haemostasis and evaluating haemostatic drugs
  24. Routine Hematological Parameters May Be Predictors of COVID-19 Severity
  25. Function, Proteomic and miRomic Study of a Dry Immersion Model of Microgravity implicates the Wnt/Dkk1/AXIN1 axis in Prothrombotic Platelet Phenotype
  26. Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension
  27. COVID-19 induces a hyperactive phenotype in circulating platelets
  28. The canine activated platelet secretome (CAPS): A translational model of thrombin‐evoked platelet activation response
  29. A review of the role of extracellular vesicles in neonatal physiology and pathology
  30. Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease
  31. Pathophysiology of the Venous Thromboembolism Risk in Preeclampsia
  32. Alterations in fibrin formation and fibrinolysis in early onset-preeclampsia: Association with disease severity
  33. Examining gender effects in different types of undergraduate science assessment
  34. Computational and experimental analysis of bioactive peptide linear motifs in the integrin adhesome
  35. Liver stiffness and thrombin generation in compensated cirrhosis
  36. Platelet-Derived Microparticles From Obese Individuals: Characterization of Number, Size, Proteomics, and Crosstalk With Cancer and Endothelial Cells
  37. The Platelet Releasate is Altered in Human Pregnancy
  38. Front Cover: Platelet Releasate Proteome Profiling Reveals a Core Set of Proteins with Low Variance between Healthy Adults
  39. Platelet Releasate Proteome Profiling Reveals a Core Set of Proteins with Low Variance between Healthy Adults
  40. Dual endothelin-1 receptor antagonism attenuates platelet-mediated derangements of blood coagulation in Eisenmenger syndrome
  41. Proteomic Analysis Reveals a Strong Association of β-Catenin With Cadherin Adherens Junctions in Resting Human Platelets
  42. Early onset preeclampsia is associated with an elevated mean platelet volume (MPV) and a greater rise in MPV from time of booking compared with pregnant controls: results of the CAPE study
  43. Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state
  44. A Protocol for Improved Precision and Increased Confidence in Nanoparticle Tracking Analysis Concentration Measurements between 50 and 120 nm in Biological Fluids
  45. Endothelial barrier protective properties of low molecular weight heparin: A novel potential tool in the prevention of cancer metastasis?
  46. Effect of platelet-derived β-thromboglobulins on coagulation
  47. Comparative proteomic analysis of trophoblast cell models reveals their differential phenotypes, potential uses, and limitations
  48. Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype
  49. Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia
  50. Analysis of the proteins associated with platelet detergent resistant membranes
  51. Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation
  52. 780: Coagulation balance in early onset preeclampsia (EOP)
  53. Canonical Wnt signaling in megakaryocytes regulates proplatelet formation
  54. WNT-3a modulates platelet function by regulating small GTPase activity
  55. Novel Platelet Signalling Pathways Identified via Proteomics
  56. Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods
  57. Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function
  58. Canonical Wnt signaling negatively regulates platelet function
  59. Differential stimulation of monocytic cells results in distinct populations of microparticles
  60. Identification of Apolipoprotein AI as a serum biomarker of chronic kidney disease in liver transplant recipients, using proteomic techniques
  61. A proteomic approach to immune-mediated epithelial-mesenchymal transition
  62. Analysis of membrane microdomain-associated proteins in the insular cortex of post-mortem human brain
  63. Role of Streptococcus gordonii Surface Proteins SspA/SspB and Hsa in Platelet Function
  64. Insights into the Platelet Releasate
  65. Recent Advances in the Characterisation of the Platelet Membrane System by Proteomics
  66. Moderation of the platelet releasate response by aspirin
  67. Correlation of probioticLactobacillus salivariusgrowth phase with its cell wall-associated proteome
  68. Using proteomics to identify potential therapeutic targets in platelets
  69. Application of Proteomics to the Study of Platelet Regulatory Mechanisms
  70. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions
  71. Integration of Proteomics and Genomics in Platelets
  72. Platelet proteomics
  73. Platelet Proteomics: Identification of Potential Therapeutic Targets
  74. Identification of the phosphotyrosine proteome from thrombin activated platelets
  75. Effects of chronic low-frequency stimulation on Ca 2+ -regulatory membrane proteins in rabbit fast muscle
  76. Oligomerisation of calsequestrin from rabbit skeletal muscle
  77. Oligomerization Is an Intrinsic Property of Calsequestrin in Normal and Transformed Skeletal Muscle
  78. Oligomerization of sarcoplasmic reticulum Ca2+-ATPase from rabbit skeletal muscle
  79. Enrichment of Phosphotyrosine Proteome of Human Platelets by Immunoprecipitation
  80. Isolation of the Platelet Releasate
  81. Platelet–Endothelial Interactions